Write a review.

Cannabinoid Biosciences Inc

Public company; Founded in 2014
6 – 10 employees

2 followers

Notes

Relationship history

  • Reminders

    No reminders

  • Notes

    No notes

  • Follow

Profile summary

Mission Cannabinoid Biosciences, Inc. (“CBDZ”), a California based Biopharmaceutical Company seeks to revolutionize and standardize the pharmaceuticals and non-pharmaceutical CBD products formulations and applications across the CBD market in the United States of America. Vision Control the production and distribution of verities of consumer cannabidiol (CBD) formulation under private brands in the United States. CBDZ’s goal is to bring standardization to the CBD industry, the same way that John D Rockefeller’s Standard Oil brought standardization to crude refining in the United States in the nineteenth century. Long Term Goals • Raise $50 million through our Regulation A+ T2 Offering Circular has been registered and was qualified by the US Securities and Exchange Commission (SEC) on April 16, 2019. • Acquire 10 (or less) dispensaries; producing has $54 million in annual revenue, from their current owners for $49 million. • Rollup the acquired dispensaries’ assets and revenue into our holding company and list on the NASDAQ or New York Stock Exchange. • Start paying out 50% of the company’s net income to shareholders. • Grow the company organically and through strategic acquisitions of complementary businesses. Strategy • Build a marketing team to build out social media and others and disseminate our message. • Direct marketing of our Regulation A+ T2 Offering and follow-through with potential investors. • Join industry groups, invite influencers to help, get free press, build out a crowdfunding platform. • Get tables at CBD, Hemp and biopharmaceutical fairs, workshops and seminars. Short Term Plans • Raise $5 million before the end of Q4 2019. • Find financing partners ASAP to leverage funds raised and start facilities acquisition. • Build company’s portfolio by start acquisitions one-dispensary-at-a-time (buy 2 dispensaries). • Rollup and consolidate the revenue and assets of acquired dispensaries and cultivation facilities.

Show more

Recent Activities

Activities